0001415889-24-020104.txt : 20240725 0001415889-24-020104.hdr.sgml : 20240725 20240725163133 ACCESSION NUMBER: 0001415889-24-020104 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240723 FILED AS OF DATE: 20240725 DATE AS OF CHANGE: 20240725 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Paolini John F. CENTRAL INDEX KEY: 0001741533 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38492 FILM NUMBER: 241142496 MAIL ADDRESS: STREET 1: C/O KINIKSA PHARMACEUTICALS, LTD. STREET 2: CLARENDON HOUSE, 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 FORMER NAME: FORMER CONFORMED NAME: Paolini John DATE OF NAME CHANGE: 20180522 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kiniksa Pharmaceuticals International, plc CENTRAL INDEX KEY: 0001730430 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 23 OLD BOND STREET, FLOOR 3 CITY: LONDON STATE: X0 ZIP: WIS 4PZ BUSINESS PHONE: 7814319100 MAIL ADDRESS: STREET 1: 23 OLD BOND STREET, FLOOR 3 CITY: LONDON STATE: X0 ZIP: WIS 4PZ FORMER COMPANY: FORMER CONFORMED NAME: Kiniksa Pharmaceuticals, Ltd. DATE OF NAME CHANGE: 20180205 4 1 form4-07252024_080729.xml X0508 4 2024-07-23 0001730430 Kiniksa Pharmaceuticals International, plc KNSA 0001741533 Paolini John F. 23 OLD BOND STREET, THIRD FLOOR LONDON X0 W1S 4PZ UNITED KINGDOM false true false false CHIEF MEDICAL OFFICER 1 Class A Ordinary Share 2024-07-23 4 M 0 22000 1.86 A 69803 D Class A Ordinary Share 2024-07-23 4 S 0 5530 25.03 D 64273 D Class A Ordinary Share 2024-07-23 4 S 0 7924 26.36 D 56349 D Class A Ordinary Share 2024-07-23 4 S 0 8446 27.10 D 47903 D Class A Ordinary Share 2024-07-23 4 S 0 100 27.87 D 47803 D Share Option 1.86 2024-07-23 4 M 0 22000 0 D 2026-09-13 Class A Ordinary Share 22000 60217 D This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023. This transaction was executed in multiple trades through a broker-dealer at prices ranging between $24.63 and $25.62. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging between $25.80 and $26.79. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging between $26.80 and $27.75. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. The option is fully vested and exercisable. /s/ Madelyn Zeylikman, Attorney-in-Fact 2024-07-25